Effectiveness of Therapeutic Exercise App Adding a Face-to-face Physical Therapist in Low Back Pain

November 2, 2022 updated by: Universidad Complutense de Madrid

Effectiveness of Therapeutic Exercise Controlled Through App Adding Face-to-face Supervision Executed by Physical Therapist in the Subacute and Chronic Low Back Pain

Low Back Pain (LBP) is one of the most usual illness in our society. Therapeutic Exercise (TE) has been shown the most effective and cheaper treatment in patients suffering LBP, but the lack of engagement to the therapeutic exercise programs is related with later acute LBP and chronic situations, despite symptoms slightly improve.

The value of personalized therapeutic exercised programs in patients suffering LBP has been shown nowadays, improving symptomatology and quality of life.

New technologies help patients to engage more in treatment, while time that health education make people "active patients".

The aim of the study is to evaluate the effectiveness of a Home Therapeutic Exercise Program (HTEP) based in an app with McGill's exercised adding 6 face-to-face sessions every 15 days with a physical therapist .

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

INTRODUCTION

Low back pain is defined as pain and discomfort, localized below the costal margin and above the inferior gluteal folds, with or without leg pain . Sub-acute low back pain as low back pain persisting between 6 and 12 weeks; chronic low back pain as low back pain persisting for 12 weeks or more. It is not usual define specific causes of LBP, no more than 15 % patients have a define cause. Non-specific low back pain is defined as low back pain not attributed to recognizable, known specific pathology (e.g. infection, tumor, osteoporosis, ankylosing spondylitis, fracture, inflammatory process, radicular syndrome or cauda equina syndrome).

LBP is one of main world health problems, 23.9 % world citizens suffer LBP over a month in their life. World aging foresee this percentage will increase more in women from 40 to 80 years old. In 2017 LBP was an important men and women chronic health problem in Spain, the second cause more important in women with 23.5 % Spanish women suffering it and the third one in men with 15.8 % Spanish men suffering it. LBP is also the most important cause of work absenteeism with general back pain and migraine.

LBP is related with sedentary lifestyle. Recurrent low back pain is usual. There are several studies searching LBP's risks and LBP's risks factors but they did not show a clear reason.

Studies about app beef up treatment engagement and treatment effectiveness. Last studies about engagement and health improvement using app had shown positive results in diabetes patients, hypertension patients, heart pathology or daily pain management without help (for example Keele Pain Recorder app).

There is a wide and proven evidence of the improvement in symptomatology using app to prescribe exercise in patients suffering LBP according to Sunil et al papers (aerobic daily programs plus 7 specific exercise towards LBP treatment), proposing health mobile apps as an important tool to chronic pathologies.

But in front of the positive situation of a better engagement, app use has a couple of limitations as the reinforcement that a face-to-face control provides ant the information that a specialist health professional can add to the app mobile development to improve the final results.

JUSTIFICATION

LBP is one of the most important health problems of our society. The present study postulates the possible link between technology and real treatment, proposing a HTEP created to non-specific LBP with an app, using McGill's Big Three exercise as the base of the program.

McGill's Big Three Exercise are 3 basic and low complexity exercises to treat any patient who is suffering non-specific low back pain, that had shown a real effectiveness in order to reduce pain intensity and to get better functionality. McGill proposed 3-exercise warm up before the Big Three "Curl up", "Side Bridge" and "Bird Dog" that had to be executed in an isometric contraction. Maximal muscular contraction had to be under 8 seconds, because longer contraction would reduce effectiveness as McGill showed in one of his studies.

The study will propose an individualized McGill Program using an app as support to the two arms of the study, and the main difference will be that experimental group will have a face-to-face control every 15 days and the control group will work only with the app.

App development has the supervision or three specialized physical therapists in LBP.

HYPOTHESIS

The addition of 6 face-to-face sessions executed by physical therapist to the personalized HTEP provided by the app is more effective at improving pain intensity, functionality, quality of life and treatment engagement in patients suffering non-specific LBP.

OBJECTIVES

General:

Evaluate the effectiveness of adding face-to-face supervision sessions executed by Physical Therapist to a HTEP with an app in people suffering non-specific LBP.

Specifics

  1. Evaluate the effectiveness of adding face-to-face supervision sessions executed by Physical Therapist to a HTEP with an app in people suffering non-specific LBP reducing pain intensity measured by PI-NRS.
  2. Evaluate the effectiveness of adding face-to-face supervision sessions executed by Physical Therapist to a HTEP with an app in people suffering non-specific LBP improving functionality measured by Oswestry scale.
  3. Evaluate the effectiveness of adding face-to-face supervision sessions executed by Physical Therapist to a HTEP with an app in people suffering non-specific LBP improving life quality of life measured by SF-12 scale.
  4. Evaluate patient satisfaction degree of a semi presential treatment measured by PSQ.
  5. Evaluate the effectiveness of adding face-to-face supervision sessions executed by Physical Therapist to a HTEP with an app in people suffering non-specific LBP improving engagement treatment analyzing app database.

METHODOLOGY

Type of study: randomized and controlled pilot study, in a two arms study with parallel interventions the experimental one and the control one. The study will blind randomization, patient assessment and data analysis. Patient randomization will take place at "Universidad Complutense de Madrid" using random permutations model of Moses and Oakford. Study characteristics itself prevent their blinded application cause:

  • Evaluators (baseline, intervention, and post-intervention) will be different professionals that physical therapist will provide face-to-face sessions, and they will ignore in which group patients are in.
  • Physical therapist that provide face-to-face sessions will not have any evaluation data.

This study will assure blinded randomization assessment, recruiters and evaluators of assessment group of each patient.

Location: Universidad Complutense de Madrid. Study Subjects: 90 patients suffering non-specific LBP

Sample size: This study has a paper published in 2018 as reference and the standard deviation was 2 in pain measure variable.

Accepting an alpha risk of 0.5 and a beta risk of 0.2 in a two-sided test, 90 subjects (45 in the control group and 45 in the experimental group) are necessary to recognize as statistically significant a difference greater than or equal to 1.5 units. The standard deviation is assumed to be 2, and it has been anticipated a drop-out rate of 10 %.

Data collection and analysis. Before starting the study, all patients will be asked to sign an informed consent in the first session where it will take place the initial assessment including the collection of patient data records and the booklet of questionnaires and clinical measurements using the app.

The patient will receive weekly 3 sessions of his personalized HTEP and experimental group will receive also 6 group session every 15 days t controlled by a physical therapist.

  1. At first session, before treatment, variables PI-NRS, SF-12 and Oswestry variables will be measured.
  2. 2 weeks after baseline, before treatment, PI-NRS variable will be measured.
  3. 4 weeks after baseline, before treatment, SF-12 and Oswestry variables will be measured.
  4. 6 weeks after baseline, before treatment, PI-NRS variable will be measured.
  5. 8 weeks after baseline, before treatment, SF-12 and Oswestry variables will be measured.
  6. 10 weeks after baseline, before treatment, PI-NRS variable will be measured.
  7. 12 weeks after baseline the patient will be re-evaluated. PI-NRS, Oswestry, SF-12, PSQ and engagement variables will be measure The following week to the end of treatment, the patient will be re-evaluated.

The statistical analysis will be performed using SPSS 22.0 program (IBM statistical software).

The average and the standard deviation of quantitative variables will be calculated for the descriptive analysis of the sample. In non-normal distributions the nonparametric sum of the ranges of Wilcoxon and Chi Square test will be performed, as well as the homogeneity in baseline will be displayed by overlapping confidence intervals.

For the comparative analysis, developed according to the intention to treat:

  1. A MANOVA (ANOVA for repeated measures) test should be carry out to evaluate the interaction between levels of inter - subject factor (treatment) and the intra- subject (main variables response in time) to be interpreted in case it is significant.
  2. To confirm whether this interaction effect is significant, pairwise comparisons will be made of the inter-subjects factor levels (treatment) for each level of main response variables over time using the Bonferroni method.

Limitations of the study and measures taken to reduce them.

Masking: The nature of the applied treatments prevents masking therapists and patients. This limitation is inherent to the type of treatment evaluated and common with other forms of treatment with similar characteristics, in which therapist should inevitably know the type of treatment that is applied.

However, this limitation does not prevent the controlled clinical trials carried out on these technologies from being of higher methodological quality. Thus, in this study, randomization of patients will be blind, allocation of the random sequence, the assessment of patient evolution and analysis of results.

Study Type

Interventional

Enrollment (Actual)

90

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Spain
      • Madrid, Spain, 28917
        • Jose Javier López Marcos

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • ≥ 18 and ≤ 65 years old.
  • Suffering low back pain.
  • In a subacute and chronic phase

Exclusion Criteria:

  • Non signature of the informed consent
  • Red Flags are risk factors detected in low back pain patients' past medical history and symptomatology and are associated with a higher risk of serious disorders causing low back pain compared to patients without these characteristics.
  • Yellow Flags are psychosocial factors that increase the risk of developing, or perpetuating chronic pain and long-term disability (including) work-loss associated with low back pain.
  • Pregnancy and lactation
  • Serious trauma or back surgery before the study
  • Illness or dysfunction of balance
  • Visual dysfunction.
  • Neurological illness, dysfunction or pain.
  • Inability to stand up and sit without help
  • Inability to read, understand and complete questionnaires, read and understand a brochure, or understand and follow verbal instructions (e.g. Illiteracy, dementia or blindness) or read, understand and use an app

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Therapeutic Exercise Controlled Through App With face-to-face
3 months treatment using app for HTEP and 6 people therapeutic exercise group every 15 days
Other: App and face-to-face physical therapy
Patients will use an app with health tests, general information about the study, personalized HTEP based in McGill's Program after their evaluations, and several online materials related with healthcare and healthy habits linked to social media sites. During the app used they will have 6 face-to-face sessions in 6 people groups with a physical Therapist in a 3 months period
Other: App physical therapy
Patients will use an app with health tests, general information about the study, personalized HTEP based in McGill's Program after their evaluations, and several online materials related with healthcare and healthy habits linked to social media sites.
Active Comparator: Therapeutic Exercise Controlled Through App
3 months treatment using app for HTEP
Other: App physical therapy
Patients will use an app with health tests, general information about the study, personalized HTEP based in McGill's Program after their evaluations, and several online materials related with healthcare and healthy habits linked to social media sites.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of participants with improve intensity of Low Back pain based in Pain Intensity- Numerical Rating Scale
Time Frame: 12 weeks treatment
Intensity of low back pain (measured by Pain Intensity- Numerical Rating Scale ( PI-NRS)) at rest. It will be valued three times with 1 min between the three valuations. 1 item, minimum value 0 and maximum value 10, and 10 is the worse value and the average will be recorded.
12 weeks treatment

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of participants with improve degree of Low Back pain disability based in Oswestry test
Time Frame: At baseline, 4 weeks treatment, 8 weeks treatmentment,12 weeks treatment and 2 months post-treatment
Low Back pain disability (measured by Oswestry test). 10 items and 10 points each item, the minimun value is 0 the maximum is 100, and 100 is the worse outcome
At baseline, 4 weeks treatment, 8 weeks treatmentment,12 weeks treatment and 2 months post-treatment
Number of participants with improve degree of quality of life based in Spanish version of the Short Form Health Survey
Time Frame: At baseline, 4 weeks treatment, 8 weeks treatmentment,12 weeks treatment and 2 months post-treatment
Quality of life (measured by a previously validated Spanish version of the Short Form Health Survey (SF-12)) 12 items, the minimun value is 12 the maximum is 55, and 55 is the worse outcome
At baseline, 4 weeks treatment, 8 weeks treatmentment,12 weeks treatment and 2 months post-treatment
Level of physical therapy intervention satisfaction based in Spanish version of the Patient Satisfaction Questionnaire
Time Frame: 12 weeks treatment
Satisfaction (measured by a previously validated Spanish version of the Patient Satisfaction Questionnaire (PSQ)) 13 items, the minimun value is 13 the maximum is 78, and 78 is the worse outcome
12 weeks treatment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Universidad Complutense de Madrid

Collaborators

FUNDACION PARA LA INVESTIGACION HOSPITAL CLINICO SAN CARLOS

Investigators

  • Principal Investigator: Jose Javier Lopez Marcos, Master, Universidad Complutense de Madrid

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2021

Primary Completion (Actual)

January 30, 2022

Study Completion (Actual)

June 30, 2022

Study Registration Dates

First Submitted

June 10, 2021

First Submitted That Met QC Criteria

July 14, 2021

First Posted (Actual)

July 23, 2021

Study Record Updates

Last Update Posted (Actual)

November 7, 2022

Last Update Submitted That Met QC Criteria

November 2, 2022

Last Verified

April 1, 2021

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • CI 19/514-E

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Low Back Pain

Clinical Trials on App and face-to-face physical therapy

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Luxembourg

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe